Status:
COMPLETED
Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Healthy
Eligibility:
All Genders
50+ years
Phase:
PHASE3
Brief Summary
This study compared the safety and tolerability profile of a higher potency investigational vaccine to that of the investigational vaccine at a lower potency dose.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy individuals 50 years of age or older with a history of chickenpox who have not had herpes zoster
- Exclusion Criteria :
- Preexisting conditions that might affect vaccine safety such as conditions that inhibit an immune response
Exclusion
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2004
Estimated Enrollment :
695 Patients enrolled
Trial Details
Trial ID
NCT00092417
Start Date
October 1 2003
End Date
June 1 2004
Last Update
October 7 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.